Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126830531 | 12683053 | 1 | I | 20160514 | 20160811 | 20160825 | 20160825 | EXP | GB-TEVA-685544ACC | TEVA | 0.00 | A | M | Y | 0.00000 | 20160825 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126830531 | 12683053 | 1 | PS | AMIODARONE | AMIODARONE | 1 | UNK | U | U | 74739 | SOLUTION FOR INJECTION | ||||||||
| 126830531 | 12683053 | 2 | SS | BISOPROLOL | BISOPROLOL | 1 | UNK | U | U | 19982 | |||||||||
| 126830531 | 12683053 | 3 | SS | DIAZEPAM. | DIAZEPAM | 1 | UNK | U | U | 70152 | |||||||||
| 126830531 | 12683053 | 4 | SS | APIXABAN | APIXABAN | 1 | UNK | U | U | 0 | |||||||||
| 126830531 | 12683053 | 5 | SS | HEPARIN | HEPARIN SODIUM | 1 | Intravenous (not otherwise specified) | UNK | Y | U | 0 | ||||||||
| 126830531 | 12683053 | 6 | SS | HEPARIN | HEPARIN SODIUM | 1 | UNK | Y | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126830531 | 12683053 | 1 | Product used for unknown indication |
| 126830531 | 12683053 | 2 | Product used for unknown indication |
| 126830531 | 12683053 | 3 | Product used for unknown indication |
| 126830531 | 12683053 | 4 | Product used for unknown indication |
| 126830531 | 12683053 | 5 | Product used for unknown indication |
| 126830531 | 12683053 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126830531 | 12683053 | HO |
| 126830531 | 12683053 | OT |
| 126830531 | 12683053 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126830531 | 12683053 | Atrial fibrillation | |
| 126830531 | 12683053 | Back pain | |
| 126830531 | 12683053 | Cardiac failure | |
| 126830531 | 12683053 | Discomfort | |
| 126830531 | 12683053 | Hepatic failure | |
| 126830531 | 12683053 | Internal haemorrhage | |
| 126830531 | 12683053 | Jaundice | |
| 126830531 | 12683053 | Malaise | |
| 126830531 | 12683053 | Monoplegia | |
| 126830531 | 12683053 | Renal failure | |
| 126830531 | 12683053 | Septic shock | |
| 126830531 | 12683053 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126830531 | 12683053 | 5 | 20160512 | 2016 | 0 |